AinB
Latest round
- Seed
Last raised
- Jan 2023
Total raised
- Undisclosed
Investors
- 2
About AinB
Based in Seoul, South Korea, and founded in 2022, Artificial Intelligence (AI) in Bioscience doing business as AinB operates as an AI-based antibody treatment company. The company (as of January 2023) is working on the discovery and development of antibodies as treatment using data based AI model. The company aims to discover immuno-oncology antibodies first to build its pipeline and to treat cancer-related diseases.
Who invested in AinB
2 investors across 1 round
See all investors in AinB
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 3, 2023
Amount
Undisclosed
Investors
Questions about AinB
Who invested in AinB?
AinB has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AinB raised?
AinB has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AinB last raise money?
AinB's most recent round on record is a Seed, in Jan 2023.
What does AinB do?
Based in Seoul, South Korea, and founded in 2022, Artificial Intelligence (AI) in Bioscience doing business as AinB operates as an AI-based antibody treatment company.
Where is AinB headquartered?
AinB is headquartered in Seoul, South Korea.
Which VCs invest in companies like AinB?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at AinB's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like AinB? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.